Melatonin and Prostate Cancer: Anti-tumor Roles and Therapeutic Application
Melatonin is an endogenous indoleamine that has been shown to inhibit tumor growth in laboratory models of prostate cancer. Prostate cancer risk has additionally been associated with exogenous factors that interfere with normal pineal secretory activity, including aging, poor sleep, and artificial light at night. Therefore, we aim to expand on the important epidemiological evidence,
Melatonin and Prostate Cancer: Anti-tumor Roles and Therapeutic Application Read More »